Amryt pharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of amryt pharma plc - amyt

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of amryt pharma plc (nasdaqgs: amyt) to chiesi farmaceutici s.p.a. under the terms of the proposed transaction, shareholders of amryt will receive $14.50 in cash plus a contingent value right of up to $2.
AMYT Ratings Summary
AMYT Quant Ranking